Walking the right path: the story of bioresorbable stents.
作者信息
Ellis Stephen
机构信息
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
出版信息
J Thorac Dis. 2017 Jul;9(7):1786-1788. doi: 10.21037/jtd.2017.06.74.
Abstract
摘要
相似文献
1
Walking the right path: the story of bioresorbable stents.踏上正确道路：生物可吸收支架的故事
J Thorac Dis. 2017 Jul;9(7):1786-1788. doi: 10.21037/jtd.2017.06.74.
2
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较：随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
3
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.冠状动脉血运重建患者中应用超薄可生物吸收聚合物西罗莫司洗脱支架与薄型持久聚合物依维莫司洗脱支架（BIOFLOW V）：一项随机试验
Lancet. 2017 Oct 21;390(10105):1843-1852. doi: 10.1016/S0140-6736(17)32249-3. Epub 2017 Aug 26.
4
The Current Literature on Bioabsorbable Stents: a Review.生物可吸收支架的最新文献综述。
Curr Atheroscler Rep. 2019 Nov 25;21(12):54. doi: 10.1007/s11883-019-0816-4.
5
Bioresorbable Stents in PCI.经皮冠状动脉介入治疗中的生物可吸收支架
Curr Cardiol Rep. 2016 Aug;18(8):74. doi: 10.1007/s11886-016-0750-9.
6
From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.从药物洗脱支架到生物可吸收支架；再到经皮冠状动脉介入治疗的新视野。
Expert Rev Med Devices. 2016;13(3):271-86. doi: 10.1586/17434440.2016.1143356. Epub 2016 Feb 12.
7
Bioresorbable stents: Current and upcoming bioresorbable technologies.生物可吸收支架：当前及即将出现的生物可吸收技术。
Int J Cardiol. 2017 Feb 1;228:931-939. doi: 10.1016/j.ijcard.2016.11.258. Epub 2016 Nov 12.
8
A review of bioresorbable scaffolds: hype or hope?生物可吸收支架综述：炒作还是希望？
Singapore Med J. 2017 Sep;58(9):512-515. doi: 10.11622/smedj.2016178. Epub 2016 Nov 21.
9
Drug-eluting bioresorbable stents for various applications.用于各种应用的药物洗脱生物可吸收支架。
Annu Rev Biomed Eng. 2006;8:153-80. doi: 10.1146/annurev.bioeng.8.013106.151418.
10
Absorb bioresorbable stents for the treatment of coronary artery disease.可吸收生物可吸收支架治疗冠状动脉疾病。
Expert Rev Med Devices. 2015;12(5):545-57. doi: 10.1586/17434440.2015.1080119.
本文引用的文献
1
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.生物可吸收支架与金属支架在常规 PCI 中的应用比较。
N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29.
2
Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.生物可吸收冠状动脉支架血栓形成：多中心临床特征、机制和预测因素的综合分析。
J Am Coll Cardiol. 2016 Mar 1;67(8):921-931. doi: 10.1016/j.jacc.2015.12.019.
3
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.载有依维莫司的聚乳酸可吸收生物支架治疗冠状动脉狭窄：5 年随访。
J Am Coll Cardiol. 2016 Feb 23;67(7):766-76. doi: 10.1016/j.jacc.2015.11.060.
4
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.依维莫司洗脱生物可吸收支架治疗冠状动脉疾病。
N Engl J Med. 2015 Nov 12;373(20):1905-15. doi: 10.1056/NEJMoa1509038. Epub 2015 Oct 12.
5
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.依维莫司洗脱生物可吸收血管支架在常规临床实践中的经皮冠状动脉介入治疗：欧洲多中心GHOST-EU注册研究的早期和中期结果
EuroIntervention. 2015 Feb;10(10):1144-53. doi: 10.4244/EIJY14M07_11.
6
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design.阿姆斯特丹研究者发起的 Absorb 策略全纳者试验（AIDA 试验）：一项比较 ABSORB 依维莫司洗脱生物可吸收血管支架治疗策略与 XIENCE 家族（XIENCE PRIME 或 XIENCE Xpedition）依维莫司洗脱冠状动脉支架治疗策略在连续全纳者治疗冠状动脉病变中的疗效和性能的临床评估：原理和研究设计。
Am Heart J. 2014 Feb;167(2):133-40. doi: 10.1016/j.ahj.2013.09.017. Epub 2013 Oct 17.
7
Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation.内皮剪切应力在支架再狭窄和血栓形成中的作用：病理生理机制及其对临床转化的意义。
J Am Coll Cardiol. 2012 Apr 10;59(15):1337-49. doi: 10.1016/j.jacc.2011.10.903.
8
Final results of the Balloon vs Optimal Atherectomy Trial (BOAT).球囊与最佳旋切术试验（BOAT）的最终结果。
Circulation. 1998 Feb 3;97(4):322-31. doi: 10.1161/01.cir.97.4.322.
9
Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry.
Circulation. 1996 Oct 1;94(7):1519-27. doi: 10.1161/01.cir.94.7.1519.
10
A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group.冠状动脉疾病患者定向旋切术与冠状动脉血管成形术的比较。CAVEAT研究组。
N Engl J Med. 1993 Jul 22;329(4):221-7. doi: 10.1056/NEJM199307223290401.
Zotero 插件